logo
Plus   Neg
Share
Email

Goldman Sachs Q3 Profit Declines, Miss Estimates - Quick Facts

The Goldman Sachs Group, Inc. (GS) reported Tuesday that net earnings applicable to common shareholders for the third quarter decreased to $1.79 billion or $4.79 per share from $2.45 billion or $6.28 per share in the year-ago quarter.

On average, 20 analysts polled by Thomson Reuters expected the company to report profit per share of $4.81 for the quarter. Analysts' estimates typically exclude special items.

Net revenues for the quarter declined 6 percent to $8.32 billion from last year, primarily reflecting lower net revenues in Investing & Lending and Investment Banking, partially offset by higher net revenues in Institutional Client Services. Analysts expected revenue of $8.31 billion for the quarter.

Institutional Client Services net revenues grew 6 percent to $3.29 billion, while Investing & Lending net revenues declined 17 percent to $1.68 billion from last year.

Net revenues in Investment Banking declined 15 percent from last year to $1.69 billion, and net revenues in Investment Management declined 2 percent to $1.67 billion from the previous year.

Provision for credit losses for the quarter was $291 million, up 67 percent from last year, primarily reflecting higher impairments.

Additionally, the Board of Directors of Goldman Sachs declared a dividend of $1.25 per common share to be paid on December 30, 2019 to common shareholders of record on December 2, 2019.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
The European Commission said Friday that it has signed a deal with Sanofi and GlaxoSmithKline to secure up to 300 million doses of their potential COVID-19 vaccine. Acella Pharmaceuticals recalled certain lots of hypothyroidism medication NP Thyroid in the form of tablets due to super potency, the U.S. Food and Drug Administration said in a statement. The company is recalling one lot of 15mg and one lot of 120mg of NP Thyroid that are packaged in 100 count bottles in strengths of 15 mg, and 120 mg, with expiration dates between October 2020 and November 2020. Walmart announced its decision to raise wages for around 165,000 hourly associates across all its U.S. stores starting October, and introduce a team-based operating model in Supercenters. In a tweet, the retail giant said, "Today we're introducing new leadership roles and cross-training opportunities, giving our associates more ways to grow their careers."
Follow RTT